The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
Targeting bone in CKD without biopsy – novel non-invasive treatment targets
CKD-MBD Working Group & IFCC
Targeting bone in CKD without biopsy – novel non-invasive treatment targets for management of CKD-MBD and CKD-associated osteoporosis
Speaker
Hanne Skou Jørgensen, Denmark
Panellists
Etienne Cavalier, Belgium
Pieter Evenepoel, Belgium
Moderator
Mathias Loberg Haarhaus, Sweden
Tuesday, April 15, 2025, at 5:00 PM (CEST)